Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts Toward Ending the Epidemic

Source :: Plus Company Updates. November 9, 2024
Publication Year :: 2024
Abstract: FOSTER CITY: Gilead Sciences, Inc has issued the following news release: Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International Congress on [...]

Subjects :: Gilead Sciences Inc.
Biological products industry -- Research -- Health aspects
HIV (Viruses) -- Prevention -- Research
Epidemics -- Research -- Prevention -- United States -- United Kingdom
Antiviral agents -- Research
Anti-HIV agents -- Research
AIDS treatment -- Research -- Health aspects
HIV infection -- Research -- Prevention
General interest
News, opinion and commentary

Tools